• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, September 5, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Nanoparticles: What is their fate and how do they change?

Bioengineer by Bioengineer
June 13, 2017
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The purpose of the international research project NANOaers (= Fate of aerosolised nanoparticles: The influence of surface active substances on lung deposition and respiratory effects) is to establish where airborne, respirable particles remain after they have been inhaled. The project is being funded in Germany by the Federal Ministry of Education and Research (BMBF). "We are also particularly interested here in the question of possible co-exposure to particles and other substances contained in aerosols," explains the president of the Federal Institute for Risk Assessment (BfR) Professor Dr. Dr. Andreas Hensel, "because nanoparticles in the air don't exist in their pristine form. They are subject to change processes when released and are usually inhaled as a mixture along with other particles and substances". This aspect is of significance, as humans and the environment are only seldom exposed to or contaminated with NM which have not already been altered by chemical substances either by their use per se or through reactions in the atmosphere. In addition to the EU countries Germany, Austria, Spain and Romania, the USA is also participating in this international research project, which is being funded to run for three years within the ERA-NET SIINN framework. The project has a total volume of approx. 1.7 million euros.

A large number of NM are added to liquids for processing before being sprayed. Well-known examples of microparticle-liquid mixtures in daily use are cleaning and impregnation sprays, such as varnishing and sealing products. Such airborne NM are described as "aerosolised" and little is known about the fate of these mixtures and if they may cause adverse health effects. Above all, the influence of the so-called matrix effects has not been investigated up to now., NM have the ability to bond other substances and carry them to otherwise inaccessible sites in the lungs of organisms.

For this reason, the NANOaers research project focuses on the question of how NM behave in the presence of other chemicals and what effects they have on humans, especially in the respiratory tract. In doing so, the potential intake of these mixtures via the respiratory system and their retention in the lungs have to be clarified. The project also examines scenarios in which nanoparticles may possibly change in their chemical and physical composition as they move through the air, and to what extent other substances are attached to them. Possible health effects are also to be examined.

To clarify these questions, realistic formulations are produced with different NM. These samples are then characterised with regard to their retention in the air and in the respiratory tract after aerosolisation using various measuring techniques, such as single particle size determination and imaging mass spectrometry. To clarify the possible effects, toxicological examinations are conducted in vitro using various cell systems, as well as in in vivo studies (with mice). Furthermore, the deposition of nanoparticles in lung tissue is aimed to be described in a model.

The results of the individual investigations obtained will all be introduced into a mathematical model, with which it should be possible to predictively describe the fate of NM in aerosol mixtures. This kind of modelling represents an important instrument to reduce the number of safety-relevant investigations of the numerous variations of NM on a long-term basis.

ERA-NET SIINN stands for European Research Area Network – Safe Implementation of Innovative Nanoscience and Nanotechnology. The reliable and rapid transfer of European nanoscience and nanotechnology research results to practical applications is promoted through this programme.

###

Media Contact

Suzan Fiack
[email protected]
0049-301-841-24300
@https://twitter.com/BfRde

http://www.bfr.bund.de/de/start.html

http://www.bfr.bund.de/en/press_information/2017/22/nanoparticles__what_is_their_fate_and_how_do_they_change_-201021.html

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Intronic Element Controls Ligase IV, Directs Thymocyte Development

September 5, 2025

Harnessing Good Vibrations: A New Era in Assisted Reproductive Technology

September 5, 2025

Skin Protein Harnesses Physical Tension to Regulate Tissue Growth

September 5, 2025

Nursing Perspectives on Outdoor Walks in Dementia Care

September 5, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    150 shares
    Share 60 Tweet 38
  • Molecules in Focus: Capturing the Timeless Dance of Particles

    142 shares
    Share 57 Tweet 36
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    115 shares
    Share 46 Tweet 29
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    61 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Intronic Element Controls Ligase IV, Directs Thymocyte Development

Scientists Convert Plastic Waste into High-Performance CO2 Capture Materials

MD Anderson and Phoenix SENOLYTIX Forge Strategic Cross-Licensing Partnership to Advance Inducible Switch Technologies in Cell and Gene Therapies

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.